In the past week, PXMD stock has gone down by -0.53%, with a monthly gain of 29.87% and a quarterly surge of 33.39%. The volatility ratio for the week is 9.11%, and the volatility levels for the last 30 days are 17.26% for PaxMedica Inc The simple moving average for the past 20 days is 6.46% for PXMD’s stock, with a -79.78% simple moving average for the past 200 days.
Is It Worth Investing in PaxMedica Inc (NASDAQ: PXMD) Right Now?
Company’s 36-month beta value is -0.16.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for PXMD is 6.78M, and currently, short sellers hold a 9.41% ratio of that floaft. The average trading volume of PXMD on May 02, 2024 was 2.42M shares.
PXMD) stock’s latest price update
PaxMedica Inc (NASDAQ: PXMD)’s stock price has gone decline by -7.61 in comparison to its previous close of 0.75, however, the company has experienced a -0.53% decrease in its stock price over the last five trading days. PennyStocks reported 2024-04-15 that Penny stocks represent an exciting opportunity for investors looking to expand their portfolios with potentially lucrative, yet cost-effective options. Typically trading below five dollars per share, these stocks offer a gateway into investing with a smaller upfront financial commitment.
PXMD Trading at 9.75% from the 50-Day Moving Average
After a stumble in the market that brought PXMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.69% of loss for the given period.
Volatility was left at 17.26%, however, over the last 30 days, the volatility rate increased by 9.11%, as shares surge +27.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.88% upper at present.
During the last 5 trading sessions, PXMD fell by -0.53%, which changed the moving average for the period of 200-days by -95.23% in comparison to the 20-day moving average, which settled at $0.6540. In addition, PaxMedica Inc saw -9.08% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PXMD starting from Rome Zachary, who sale 811 shares at the price of $0.48 back on Jan 29 ’24. After this action, Rome Zachary now owns 15,148 shares of PaxMedica Inc, valued at $389 using the latest closing price.
Weisman Howard J., the Chief Executive Officer of PaxMedica Inc, sale 372 shares at $0.47 during a trade that took place back on Jan 29 ’24, which means that Weisman Howard J. is holding 37,675 shares at $175 based on the most recent closing price.
Stock Fundamentals for PXMD
The total capital return value is set at -4.16. Equity return is now at value -1046.96, with -463.93 for asset returns.
Currently, EBITDA for the company is -16.15 million with net debt to EBITDA at 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.16.
Conclusion
In a nutshell, PaxMedica Inc (PXMD) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
